<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-22T07:11:13Z</responseDate><request verb="GetRecord" identifier="oai:gupea.ub.gu.se:2077/37998" metadataPrefix="dim">https://gupea.ub.gu.se/server/oai/request</request><GetRecord><record><header><identifier>oai:gupea.ub.gu.se:2077/37998</identifier><datestamp>2015-03-31T01:34:20Z</datestamp><setSpec>com_2077_284</setSpec><setSpec>com_2077_17</setSpec><setSpec>com_2077_10556</setSpec><setSpec>col_2077_305</setSpec><setSpec>col_2077_310</setSpec><setSpec>col_2077_10557</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author">Öst, Martin G</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2015-03-30T07:27:33Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2015-03-30T07:27:33Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2015-03-30</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="isbn">978-91-628-9291-3 (print)</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="isbn">978-91-628-9292-0 (electronic)</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/2077/37998</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="sv">Background: Severe traumatic brain injury (sTBI) is the most common cause of&#xd;
mortality in young adults. sTBI induces variable brain damage, invisible in Computer&#xd;
Tomographic scans early post-trauma. Further, neurology is difficult to evaluate in&#xd;
sedated patients. Therefore, biochemical neuromarkers (BNMs) in blood or&#xd;
cerebrospinal fluid (CSF) may be valuable tools to both evaluate trauma and to&#xd;
prognosticate patient outcome.&#xd;
Aims: The aim of the thesis was to evaluate if concentrations of the BNMs; Glial&#xd;
Fibrillary Acid Protein (GFAP, CSF, study IV), Neurofilament light (NFL, CSF,&#xd;
study IV), Tau (CSF, study II), β-amyloid (1-42) and amyloid precursor-proteins&#xd;
(CSF &amp;amp; plasma, study I) were enhanced after a sTBI. Further, we investigated if&#xd;
these levels were correlated to outcome, neurology and patient ability of daily living&#xd;
1-year post-trauma. Finally, we explored if patient-genotype, specifically&#xd;
Apolipoprotein E, (gene APOE), influenced 1-year outcome in sTBI-patients,&#xd;
(plasma, study III).&#xd;
Methods: Patients were consecutively included if; aged ≥7 years, &amp;lt; 9 in Glasgow&#xd;
Coma Scale, receiving an indwelling ventricular catheter allowing CSF sampling),&#xd;
were artificially ventilated and admitted to the Neurointensive care unit (NICU)&#xd;
within 48h post-trauma. NICU-care was performed according to a standardized&#xd;
protocol. CSF samples were collected on days 0-4, 6, 8 and once on days 11-18.&#xd;
Surviving patients were assessed at 1-year evaluating; 1) outcome by Glasgow&#xd;
Outcome Scale (GOS), 2. neurology and 3. activities of daily living. NFL, GFAP,&#xd;
Tau, β-amyloid (1-42) and amyloid precursor-proteins were all analyzed by ELISAmethods.&#xd;
APOE genotyping was performed by polymerase chain reaction &amp;amp; solidphase&#xd;
mini-sequencing.&#xd;
Results: During the inclusion period, patients (n=28-96) were included into studies IIV&#xd;
for CSF and /or blood sampling. Study I; β-amyloid (1-42) and amyloid&#xd;
precursor-proteins increased from day 0 until day 11 in the CSF, but not in plasma. In&#xd;
study II we found enhanced levels of CSF-Tau on days 2-3 correlated to mortality&#xd;
(GOS 1) at 1-year. In study III we found that patients with APOE allele 4 had worse&#xd;
outcome (GOS) at 1-year. Finally, in paper IV we found increased CSF levels of&#xd;
GFAP and NFL both correlating to outcome (GOS) at 1-year.&#xd;
Conclusions; In this thesis we have found in sTBI-patients that genetic and BNMs in&#xd;
the plasma and/or CSF correlate to outcome at 1 -year post-trauma. The result may&#xd;
be clinically applicable to prognosticate outcome and influence treatment paradigms&#xd;
in these patients.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="sv">eng</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart" lang="sv">I Olsson A, Csajbok L, Ost M, Höglund K, Nylén K, Rosengren L, Nellgård B,&#xd;
Blennow K.  Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury. J Neurol. 2004&#xd;
 Jul;251(7):870-6. ::PMID::15258792</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart" lang="sv">II  Ost M, Nylén K, Csajbok L, Ohrfelt AO, Tullberg M, Wikkelsö C, Nellgård P,&#xd;
Rosengren L, Blennow K, Nellgård B.  Initial CSF total tau correlates with 1-year &#xd;
outcome in patients with traumatic brain injury. Neurology. 2006 Nov 14;67(9):1600-4. ::PMID:: 17101890</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart" lang="sv">III Ost M, Nylén K, Csajbok L, Blennow K, Rosengren L, Nellgård B.  Apolipoprotein &#xd;
E polymorphism and gender difference in outcome after severe traumatic brain&#xd;
injury. Acta Anaesthesiol Scand. 2008 Nov;52(10):1364-9. ::PMID:: 19025529</dim:field>
   <dim:field mdschema="dc" element="relation" qualifier="haspart" lang="sv">IV M. Öst, K. Nylén, L. Csajbok, H. Zetterberg, K. Blennow and B. Nellgård.  CSF concentrations of glial fibrillary acidic protein and neurofilament light correlate with 1-year outcome after severe traumatic brain injury.&#xd;
Submitted for publication (2015)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="sv">Traumatic brain injury</dim:field>
   <dim:field mdschema="dc" element="subject" lang="sv">outcome</dim:field>
   <dim:field mdschema="dc" element="subject" lang="sv">NFL</dim:field>
   <dim:field mdschema="dc" element="subject" lang="sv">GFAP</dim:field>
   <dim:field mdschema="dc" element="subject" lang="sv">tau</dim:field>
   <dim:field mdschema="dc" element="subject" lang="sv">β-amyloid</dim:field>
   <dim:field mdschema="dc" element="subject" lang="sv">apolipoprotein E</dim:field>
   <dim:field mdschema="dc" element="subject" lang="sv">biochemical neuromarkers</dim:field>
   <dim:field mdschema="dc" element="title" lang="sv">Prediction value of genetic and neuromarkers in blood and liquor in patients with severe traumatic brain injury</dim:field>
   <dim:field mdschema="dc" element="type" lang="eng">text</dim:field>
   <dim:field mdschema="dc" element="type" qualifier="svep" lang="eng">Doctoral thesis</dim:field>
   <dim:field mdschema="dc" element="type" qualifier="degree" lang="sv">Doctor of Philosophy (Medicine)</dim:field>
   <dim:field mdschema="dc" element="gup" qualifier="mail" lang="sv">martin.ost@gmail.com</dim:field>
   <dim:field mdschema="dc" element="gup" qualifier="origin" lang="sv">University of Gothenburg. Sahlgrenska Academy</dim:field>
   <dim:field mdschema="dc" element="gup" qualifier="department" lang="sv">Institute of Clincial Sciences. Department of Anesthesiology &amp;amp; Intensive Care Medicine</dim:field>
   <dim:field mdschema="dc" element="gup" qualifier="defenceplace" lang="sv">Fredagen den 17 April 2015, Hörsal Arvid Carlsson, Academicum Medicinaregatan 3</dim:field>
   <dim:field mdschema="dc" element="gup" qualifier="defencedate">2015-04-17</dim:field>
   <dim:field mdschema="dc" element="gup" qualifier="dissdb-fakultet">SA</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>